|
Volume 271,
Number 1,
Issue of January 5, 1996 pp. 48-55
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Secretory Granule
Content Proteins and the Luminal Domains of Granule Membrane Proteins
Aggregate in Vitro at Mildly Acidic pH (*)
(Received for publication, August
14, 1995)
Veronica
Colomer (§),
,
Gregory A.
Kicska
,
Michael
J.
Rindler (¶)
From the Department of Cell Biology and Kaplan Cancer Center,
New York University Medical Center, New York, New York 10016
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES
ABSTRACT
A major unresolved issue in the field of secretory granule
biogenesis is the extent to which the aggregation of granule content
proteins is responsible for the sorting of regulated from
constitutively secreted proteins. The aggregation process is postulated
to take place in the trans-Golgi network and immature
secretory granules as the proteins encounter mildly acidic pH and high
calcium concentrations. We have developed in vitro assays that
reconstitute the precipitation out of solution of secretory granule
content proteins of anterior pituitary gland and adrenal medulla. In
the assays, all of the major granule content polypeptides form a
precipitate as the pH is titrated below 6.5, and this precipitate can
be recovered in the pellet fraction after centrifugation. Addition of
calcium is required for the aggregation of chromaffin granule content.
In contrast to the proteins secreted by the regulated pathway, the
constitutively secreted proteins IgG, albumin, and angiotensinogen,
when added to the assays, remain predominantly in the supernatant.
Among the individual proteins tested, prolactin is found to aggregate
homophilically under these conditions and can drive the co-aggregation
of other proteins, such as the chromogranins. Soluble forms of granule
membrane proteins, including dopamine -hydroxylase and peptidyl
glycine -amidating enzyme also co-aggregated with granule content
proteins. The results are consistent with the idea that spontaneous
aggregation of proteins occurring under ionic conditions similar to
those at the sites of granule formation is a property restricted to
those proteins packaged in secretory granules. In addition, the
association of luminal domains of membrane proteins with content
proteins in vitro raises the possibility that analogous
interactions between membrane-bound and content proteins also occur
during granule formation in intact cells.
INTRODUCTION
A hallmark of secretory granules is the presence within them of
condensed cores containing aggregated content proteins. Morphological
studies have indicated that the formation of these cores begins in
dilated extensions of the trans-Golgi network (TGN) ( )(1, 2) and continues in the immature
secretory granules/condensing vacuoles (ISG) that are intermediates in
the granule formation process(3) . Progressive condensation of
the content proteins occurs during maturation of the ISGs into mature
secretory granules. During the process of secretory granule
formation, the granule content and membrane proteins are segregated
from molecules constitutively transported to the plasma membrane. This
segregation is thought to occur both in the TGN and in the
ISGs(4, 5, 6) . A major unresolved issue is
what role spontaneous protein aggregation has in this sequestration of
the granule-specific proteins, particularly for the content proteins.
Most of the available information concerning the aggregative properties
of granule content proteins has derived from the observed in vitro behavior of the chromo/secretogranins (Cg), which can aggregate at
mildly acidic pH in the presence of
calcium(4, 7, 8) , conditions thought to
resemble those existing in the TGN(9) . If aggregation
mediated sorting is to be a general mechanism for the segregation of
regulated from constitutively secretory proteins then several criteria
should be met. First, granule content proteins should aggregate under
the ionic and pH conditions thought to be present in the TGN even in
cells where Cgs are minor components or not present. Second,
constitutively secreted proteins should not be able to co-aggregate
with the granule content proteins. In previous studies where the
aggregation of Cgs was examined either in vitro or in
detergent-treated cell extracts, the behavior of the other granule
content proteins or well characterized constitutively secreted proteins
was not examined systematically(4, 7, 8) . To test whether aggregation of content proteins can potentially
mediate the targeting of proteins to secretory granules, we have
developed assays to measure protein aggregation in vitro. In
these assays, granule content proteins undergo pH-dependent aggregation
in a process that excludes constitutively secreted proteins. Some of
the content proteins aggregate at low pH when assayed individually in
the absence of the other proteins, while others require an aggregating
partner to precipitate. Soluble forms of membrane-associated proteins
also undergo co-aggregation with the content proteins under conditions
where they do not self-associate. The results are consistent with a
potential role for protein aggregation in the segregation of both
secretory and membrane proteins to storage granules.
MATERIALS AND METHODS
Antibodies and Purified Granule Content
ProteinsRabbit antibodies to dopamine- -hydroxylase (DBH)
prepared against the purified protein from bovine adrenal gland (10) were generously provided by Dr. R. Angeletti (Albert
Einstein College of Medicine, Bronx, NY). Rabbit anti-bovine CgA
antibody was a generous gift of Dr. D. Aunis (Centre de Neurochimie du
CNRS, Strasbourg, France), and purified rat peptidyl glycine
-amidating enzyme (PAM3) and rabbit anti-PAM (PAL) antibodies were
a generous gift of Drs. B. Eipper and R. Mains (Johns Hopkins
University School of Medicine, Baltimore, MD). Antibody to growth
hormone (GH) was purchased from Accurate Chemical (Westbury, NY) while
anti-ACTH was obtained both from Accurate and from Sigma, with similar
results obtained for each. Antibodies to prolactin (Prl), luteinizing
hormone (LH), and follicle stimulating hormone (FSH) were obtained from
the NIDDK National Hormone and Pituitary Program as were human GH and
LH. Bovine serum albumin (BSA), rabbit and human IgG, Prl, and
chymotrypsinogen were purchased from Sigma. Angiotensinogen was from
Calbiochem. I-Human recombinant IGF-1 (2000 Ci/mmol) was
purchased from Amersham and was reconstituted and stored according to
the manufacturer's recommendation. Porcine POMC was obtained from
conditioned medium from transfected LLC-PK1 cells expressing the
full-length molecule (a gift of Dr. G. Boileau,
Université de Montreal, Canada).
Preparation of Granule Content ProteinsBovine
pituitaries were decapsulated, minced, and homogenized in 0.32 M sucrose with protease inhibitors. After centrifugation at 750
g to remove unbroken cells and nuclei, a crude granule
preparation was obtained by centrifugation of the postnuclear
supernatant at 8750 g for 20 min in a Sorvall RC2-B
centrifuge (DuPont). Samples were layered onto 1.6 M sucrose
and pelleted at 150,000 g for 120 min using a Ti60
rotor and a L8-55 centrifuge (Beckman). The granule pellets were
lysed by sonication in phosphate-buffered saline, pH 9, with 100 mM KCl and aprotinin (10 KIU/ml) added, and the soluble content was
recovered after centrifugation at 100,000 g for 30
min. Adrenal chromaffin granules were prepared from fresh bovine
adrenal medulla using the same procedure (11) . Granules were
lysed by freeze thawing and sonication in 100 mM KCl, 25
mM HEPES pH 7.5, in the presence of protease inhibitors. The
released content proteins were recovered after centrifugation as
described previously(12) .
In Vitro Aggregation AssayGranule contents or
isolated proteins were de-salted over Bio-Gel P-6 DG columns (Bio-Rad)
equilibrated with 5.5 mM HEPES pH 7.5. When necessary, protein
stock solutions were concentrated using Centricon (Amicon) or Filtron
(Northborough, MA) concentrators. Just before use, the samples were
pre-spun for 30 min at 15,000 g in an Ependorf
centrifuge or 56,000 g for 30 min in a Ti100.3 rotor
using a Beckmann TL100 ultracentrifuge, and the pellet was discarded. A
procedure similar to that described previously was
employed(12) . Briefly, 50-µl samples containing granule
content or the proteins of interest (1-4 mg/ml final
concentration) in 5 mM HEPES, 10 mM MES, pH 7.5, were
titrated slowly to the indicated pH values by adding 0.125 N HCl while vortexing. KCl or CaCl were added in some
experiments where indicated. After incubation for 15-30 min at 23
°C, the reaction mixture was centrifuged to separate the pelleted
precipitates from the supernatant fractions. Centrifugation in most
cases was for 30 min at 15,000 g in an Ependorf
centrifuge. In experiments using adrenal chromaffin extracts in the
presence of calcium, centrifugation was conducted at 43-56,000
g in a TL100 ultracentrifuge. This procedure increased
the magnitude of the observed precipitates but did not qualitatively
change the overall results. A portion of the supernatant and the entire
pellet fractions were then subjected either to a BCA protein
determination assay (Pierce) or to SDS-PAGE (run without reducing agent
except where indicated) followed by staining of the gels with Coomassie
Blue and, when appropriate, autoradiography. As a routine control,
samples were subjected to the assay but not centrifuged. The amounts of
protein remaining in the tubes after removal of the assay mixture were
inconsequential so long as the overall protein concentrations were at
least 1.5 mg/ml, indicating that the observed recovery of protein in
the pellet fractions was not due to binding to the assay tubes. BSA or
hemoglobin were added as carriers to minimize binding to the tubes of
test proteins used at low concentrations, such as IGF-1 or PAM.
Immunoblotting and IodinationImmunoblotting was
performed after SDS-PAGE, transfer of the proteins to nitrocellulose
paper, and staining with Ponceau S to visualize the transferred
proteins. I-Protein A (DuPont NEN) was used in some
experiments as the second step as described previously(12) . In
other cases, the ECL procedure was employed (Amersham). Iodination of
proteins was performed using the lactoperoxidase method(13) .
Quantitation of the radioactivity was performed using a Molecular
Dynamics PhosphorImager. In some cases images from the PhosphorImager
or from digitalized images (LACIE Ltd., Beaverton, CA) of gels stained
with Coomassie Blue or Ponceau S were imported into Quark Express
(Denver, CO) for computerized labeling and printing of figures.
RESULTS
Secretory Granule Content Proteins Precipitate in a
pH-dependent MannerSecretory granule content was obtained from
bovine pituitary glands as described under ``Materials and
Methods.'' When the pH of the pituitary samples was titrated from
7.5 to below 6.5, content proteins precipitated out of solution and
could be recovered in the pellet fraction after centrifugation (Fig. 1). As much as 60% of the total protein aggregated as the
pH was reduced to 5.5 under these conditions. Addition of 150 mM KCl and/or 10 mM CaCl (up to 40 mM in some experiments) had no significant effect on the overall
aggregation of the pituitary content proteins (Fig. 1).
Figure 1:
Pituitary granule content proteins
aggregate when the pH is reduced. Secretory granule content (2 mg/ml)
was prepared from bovine pituitary gland and equilibrated with 5 mM HEPES, 10 mM MES, pH 7.5. The pH was reduced as indicated
and the pellet and supernatant fractions recovered as described under
``Materials and Methods.'' The protein in both fractions was
measured and is plotted as the mean and standard error of the protein
in the pellet as a percentage of the total (pellet + supernatant).
150 mM KCl and 10 mM CaCl were added
where indicated. In both cases, aggregation began by pH 6.5 and
increased as the pH was reduced further.
When
analyzed by SDS-PAGE, all of the major proteins in the granule content
were observed to precipitate as the pH was reduced (Fig. 2).
This effect was also reversed when the pH was retitrated back to 7.5 (Fig. 2, right panel). The two most prominent proteins
were identified as Prl and GH based on the migration positions of the
purified proteins and immunoblotting using specific antibodies (data
not shown). Thus, these granules, as is typical for purified pituitary
granules(14) , consist primarily of those from somatotrophs and
mammotrophs, the most abundant cells in the pituitary. However, other
known pituitary proteins could be identified by immunoblot analysis
using specific antibodies. A pH-dependent aggregation was observed for
LH, FSH, and chromogranin A (CgA) (Fig. 3). In addition, a
37-kDa protein reacting with anti-ACTH antibodies underwent
pH-dependent aggregation as well (Fig. 3). This protein
co-migrated on polyacrylamide gels with authentic porcine POMC. In
general, all of these pituitary proteins aggregated as well as did GH
and Prl in the same experiments.
Figure 2:
The major pituitary secretory granule
content proteins aggregate at mildly acidic pH. Granule content from
bovine pituitary gland was utilized in the standard assay (see Fig. 1). Left panel, the pH was reduced to 6.2 or 5.5.
The entire pellet (P) (lanes c, f, and i),
20% of the initial sample (I) (lanes a, d, and g), and 20% of the remaining supernatant (S) after
centrifugation (lanes b, e, and h) were then
subjected to SDS-PAGE and the gel was stained with Coomassie Blue. The
migration positions of the indicated proteins, prolactin (Prl) and
growth hormone (GH), were determined from those of the corresponding
purified proteins and confirmed by immunoblotting using appropriate
antibodies. Note the greatly increased appearance of the major proteins
in the pellets after pH reduction (lanes f and i).
For Prl, the percent aggregation at pH 7.5, 6.2, and 5.5 was 4, 14, and
21%, respectively, and the corresponding values for GH were 7, 35 and
44%. The migration positions of prestained marker proteins are
indicated at the right margin. Presented is one of three
similar experiments. Right panel, the reversibility of the
pH-dependent aggregation was measured after reduction of the pH to 5.5,
incubation for 30 min, and retitration back to pH 7.5. Control samples
were maintained for 30 min at pH 7.5 and 5.5, respectively. The amounts
of Prl and GH in the pellets and supernatants were measured by
densitometric scanning of digitalized images of the Coomassie-stained
gels and are presented as the overall mean and standard error of three
separate experiments.
Figure 3:
The major pituitary hormones precipitate
at mildly acidic pH. Granule content (3 mg/ml) prepared from bovine
pituitary glands was subjected to the aggregation assay at either pH
7.5 (lanes a and b) or 5.6-5.8 (lanes
c and d). Pellet (P; lanes a and c) and
30% of the supernatant (S; lanes b and d) fractions
were subjected to SDS-PAGE and transfer to nitrocellulose. The
indicated proteins were identified by immunoblotting using specific
antibodies followed by the ECL procedure (in the case of POMC) or by I-protein A and autoradiography. All of the content
proteins underwent pH-dependent aggregation, including FSH (4% at pH
7.5 versus 50% at pH 5.6), LH (3% at pH 7.5 versus 24% at pH 5.6), and chromogranin A (CgA; 2% at pH 7.5 versus 48% at pH 5.6). As expected, GH, included as a control, was found
predominantly in the pellet fraction at low pH (6% at pH 7.5 versus 42% at 5.6). 37-kDa POMC, from a separate experiment, also
underwent pH-dependent aggregation (6% at pH 7.5 versus 39% at
pH 5.6 after normalization for differences in Prl/GH aggregation). In
each case, the results represent one of two similar
experiments.
To extend these results to other
types of secretory granule content, the same assay was conducted with
purified adrenal chromaffin granule content proteins, consisting almost
entirely (>90%) of the Cgs. Unlike what was observed using the
pituitary granule content, the chromaffin granule proteins when used at
2 mg/ml did not undergo pH-dependent aggregation (Fig. 4).
Aggregation did occur, however, when calcium was added (Fig. 4)
and this effect was greater as the pH was reduced. The aggregation was
also reversible. In three separate experiments where the pH was lowered
to 5.6 in the presence of 20 mM CaCl and, after a
30-min incubation, titrated back to pH 7.5, the recovery of CgA in the
pellets was reduced to the level of the pH 7.5 control (data not
shown). The concentration of calcium required for maximal aggregation
was 20 mM (not shown), higher than the 10 mM believed to be present in the TGN (4) but lower than the
40 mM present in mature chromaffin granules(15) . The
high calcium requirement is likely to be due to the relatively low
concentrations of protein employed, far lower than that of mature
granules (>100 mg/ml). It has been already established that
aggregation of CgA in vitro requires less calcium as the
protein concentration is increased(8) . Thus, the overall
aggregation of adrenal content is consistent with that expected for the
chromogranins themselves.
Figure 4:
Adrenal chromaffin granule content
proteins aggregate in the presence of calcium. Granule content (2
mg/ml) was obtained from bovine adrenal medulla as described under
``Materials and Methods.'' This content was subjected to the
standard aggregation assay in the presence or absence of 40 mM CaCl . Total protein in the pellets was measured and is
plotted as the mean ± S.E. Little precipitation of the
chromaffin granule content was observed in the absence of
CaCl , or in the presence of 150 mM KCl and 10
mM CaCl (not shown). However, when high
concentrations of CaCl were used, aggregation did occur,
with increased aggregation at lower pH.
Constitutively Secreted Proteins Are Excluded from the
Precipitate Formed by Granule Content ProteinsIf aggregation is
to play a role in the segregation of constitutively secreted proteins
from granule content proteins, then the constitutively secreted
proteins should not aggregate together with the content proteins. To
assess whether this would be the case in the in vitro assays,
three constitutively secreted proteins were added individually to the
pituitary content proteins prior to the reduction of the pH. As shown
in Table 1, IgG, angiotensinogen, and albumin, all proteins that
are known to be constitutively secreted from transfected endocrine cell
lines(16, 17, 18) , were recovered almost
exclusively in the supernatant fractions. The mean aggregation of these
proteins was 5% or less as compared to 29 and 37% for Prl and GH,
respectively. These observations resemble those we have previously
obtained using a soluble version of the pancreatic zymogen granule
membrane protein GP2(12) . GP2, which is constitutively
secreted from pituitary AtT20 cells, also does not co-aggregate with
pituitary content proteins.
A similar set of experiments was
conducted using chromaffin granule content proteins induced to
aggregate in the presence of calcium. As shown in Fig. 5, none
of the three constitutive markers, IgG, angiotensinogen, or BSA,
co-aggregated effectively (<5%) with the adrenal content proteins,
whereas CgA, the major content protein, did precipitate well
(30-39% at pH 5.6). Taken together, these data show that
protein-protein interactions occurring during protein aggregation are
specific and that constitutively secreted proteins aggregate less
efficiently than granule content proteins, at least in vitro.
Figure 5:
Constitutively secreted proteins do not
co-aggregate with adrenal chromaffin granule content proteins. Granule
content (2 mg/ml) from adrenal medulla was subjected to the aggregation
assay at the indicated pH values in the presence of 25 mM CaCl after addition of I-labeled
angiotensinogen (Ang) and unlabeled rabbit IgG (panel
A) or I-labeled BSA (panel B). Pellets (P; lanes a and c) and 20% of the supernatants (S; lanes b and d) were analyzed after SDS-PAGE (no
reducing agent was added) by autoradiography on a PhosphorImager (panels A and B, top) or by Coomassie Blue
staining of the gel (panels A and B, bottom). These markers of the constitutive pathway did not
co-precipitate significantly with granule content proteins in the
presence of CaCl . At pH 5.6, 5% of angiotensinogen, 4% of
IgG, and 0% of BSA were detected in the pellet fractions as compared to
30% (panel A) and 39% (panel B) for CgA. For each
constitutive protein, the results represent one of two similar
experiments.
Insulin-like Growth Factor I (IGF-1) Also Co-aggregates
with Granule Content ProteinsIt has been recently shown that
IGF-1 is targeted to the regulated secretory pathway in AtT20
cells(19) . However, IGF-1 in secretory granules did not
aggregate when detergent-permeabilized AtT20 cells were incubated at pH
6.4 in the presence of 10 mM calcium. Moreover, proinsulin,
which is highly similar to IGF-1 in its amino acid sequence, did not
undergo pH-dependent co-aggregation with chromogranins in
detergent-permeabilized PC12 cells even when accumulated prior to the
assay in the TGN(19) . To determine whether IGF-1 is an
exceptional molecule that is targeted to secretory granules but does
not co-aggregate with other granule content proteins, I-IGF-1 was added to the in vitro aggregation
assays together with pituitary or adrenal chromaffin content proteins.
As shown in Fig. 6, IGF-1 co-aggregated well at reduced pH in
the pituitary assays (panel A) and reasonably well at reduced
pH in the presence of calcium in the adrenal assays (panel B).
In control experiments, IGF-1 failed to precipitate significantly when
incubated at low pH with only BSA present, indicating that it does not
self-associate under these conditions (data not shown). Thus, the
targeting of IGF-1 to secretory granules in vivo does
correspond to its behavior in the in vitro aggregation assays.
Figure 6:
IGF-1 also co-aggregates with granule
content proteins. I-Labeled IGF-1 (10,000 cpm) was added
to the aggregation assays together with content proteins from pituitary (panel A) or adrenal medulla (heat-treated; panel B).
The assays were conducted as described in the legends to Fig. 1and Fig. 4for pituitary and adrenal, respectively,
at the pH values indicated with 40 mM calcium in the adrenal
samples at pH 6.4 and 5.9. Total protein in the pellet and supernatant
fractions was measured using a BCA assay while I was
determined by counting on a -counter. The mean and standard error
of triplicate samples are presented after correcting for free I (10%). IGF-1 co-aggregated with both the pituitary and
adrenal content proteins at low pH.
A Role for Self-aggregating Proteins in Content Protein
PrecipitationAs was shown in Fig. 2, all of the
regulated secretory proteins detectable in the pituitary gland content
precipitated as the pH was lowered. It is unlikely that this result was
due entirely to homophilic self-aggregation of the proteins themselves.
CgA, for example, which was found to aggregate in the pituitary
content, did not form precipitates under the same conditions when the
adrenal content alone was used (Fig. 4). However, to examine
this issue in more detail, the inherent capacity of individual
polypeptides to undergo pH-dependent precipitation was analyzed using
purified granule content proteins. Among the pituitary hormones tested (Fig. 7), Prl was the only one to undergo strong pH-dependent
aggregation. LH did not aggregate detectably, while GH did aggregate
somewhat in the absence of added salt. BSA and human IgG were also
tested in the assay (Fig. 7) and as expected, they did not
precipitate as the pH was reduced. It is important to note that the
aggregation does not, in general, correlate with the isoelectric point
of the proteins. Although bovine prolactin has its pI in this range
(5.8), so also do BSA (5.1), angiotensinogen ( 6.0), and bovine
chymotrypsinogen ( 6.0; data not shown), which do not aggregate in
the assay.
Figure 7:
Prolactin, but not other pituitary granule
content proteins, homotypically self-aggregates at reduced pH. Bovine
Prl, human GH, and ovine LH were subjected to the standard aggregation
assay (see Fig. 1). 150 mM KCl and 10 mM CaCl was included in one set of the samples as
indicated. Total protein in the supernatants and pellets was measured
in triplicate samples and is plotted as the mean ± S.E., which
in most cases was too small to be represented on the graph. Prolactin
underwent a strong self-aggregation as the pH was reduced <6.5. This
aggregation was not affected by the addition of salt. GH did not
aggregate well, although some pH-dependent aggregation was detected in
the absence of salt (up to 12% in some experiments). By contrast, LH
and the constitutively secreted proteins, IgG and BSA, did not
self-aggregate detectably under these
conditions.
CgA, GH, and LH, which did not self-associate under these
conditions, did undergo substantial aggregation in the pituitary
content itself (Fig. 2), implying that their aggregation, at
least in vitro, is dependent on their interaction with other
proteins in the mixture, perhaps self-aggregating proteins like
prolactin. To investigate these types of protein-protein interactions,
Cgs, in the form of adrenal content, and purified LH were added to Prl
and the pH reduced so as to initiate Prl aggregation. Prl itself was
capable of driving the aggregation of the major chromaffin granule
proteins, including CgA (data not shown), suggesting that these
proteins could potentially interact during granule formation. LH, on
the other hand, remained mostly if not entirely soluble when mixed with
Prl alone in the assay (Fig. 8A), illustrating the
specificity of the protein-protein interactions that occur at low pH.
The aggregation of LH could be induced, however, by including LH
together with adrenal content and Prl. In other words, the aggregation
of LH was dependent upon its interaction with proteins in the adrenal
content, most likely chromogranins, which in turn can associate with
the aggregating Prl. Addition of the same amount of LH to assays
conducted with pituitary extracts led to a similar level of aggregation
of LH (not shown). To analyze directly the potential interaction of LH
with adrenal content proteins, this hormone was added to adrenal
content and Cg aggregation was induced in the presence of calcium. As
depicted in Fig. 8B, LH was also induced to
co-precipitate together with the Cgs in the presence of calcium,
whereas neither LH nor the Cgs aggregated in its absence.
Figure 8:
Co-aggregation of luteinizing hormone with
adrenal components occurs in the presence of prolactin or calcium. Panel A, aggregation assays were performed as described in the
legend to Fig. 2at pH 5.8 using 2 mg/ml LH alone (lanes a and b), Prl alone (lanes c and d), Prl
together with LH (lanes e and f), Prl, LH together
with adrenal content (lanes g and h), and LH together
with pituitary content (lanes i and j). Pellet (P; lanes a, c, e, g, and i) and 20% of the
supernatant (S; lanes b, d, f, h, and j) fractions
were subjected to SDS-PAGE in the absence of reducing agent (lanes
g and h are from a separate gel). Prl by itself failed to
induce the aggregation of LH (lanes e and f).
However, LH did sediment when added together to adrenal content in the
presence of Prl (lanes g and h). CgA also sedimented
when Prl was mixed with adrenal content under these conditions whether
LH was present (lanes g and h) or not (not shown). Panel B, the aggregation assays were performed as in Fig. 5. LH (lanes e and f), adrenal content (lanes c and d, g and h), and a mixture of
both (lanes c and d, i and j) were incubated
in the absence (lanes a-d) or presence (lanes e-j) of
25 mM CaCl . In the absence of CaCl both LH and CgA failed to aggregate. In the presence of calcium,
however, LH co-precipitated with the aggregating adrenal proteins,
including CgA. The percent aggregation (% Aggreg.) obtained
for each of the indicated proteins is listed at the bottom. The results
indicate that LH can interact directly with chromaffin content proteins
at low pH. It will sediment when the aggregation of Cgs is induced
either by calcium or by Prl. Presented is one of two similar
experiments.
These
results are in agreement with observations made in vivo concerning the packaging of these proteins in secretory granules.
Cgs and Prl are packaged together in the granules of pituitary-derived
cell lines in culture and in rat mammotrophs, while LH and
chromogranins appear in the same granules in pituitary
gonadotrophs(20, 21, 22) .
Co-aggregation of the Luminal Domains of Granule Membrane
Proteins with Content ProteinsProtein aggregation could
potentially play a role in the segregation of membrane-associated
proteins to secretory granules, particularly if these membrane proteins
interact with content proteins in the TGN and ISG. For this to occur
during granule formation in vivo, the luminal domains of
membrane proteins would need to associate with content proteins at
acidic pH. To test whether interactions of this nature could occur in vitro, we have taken advantage of the fact that many
granule membrane proteins, including DBH and PAM, have soluble forms
that are present in the granule content. DBH is a major chromaffin
granule membrane protein which consists of a membrane-bound tetramer
with two subunits firmly attached to the membrane and two subunits
which exchange with a soluble pool found in the content(23) .
PAM is synthesized as a transmembrane precursor, but a portion of it is
processed to yield soluble forms, consisting of segments of the luminal
domain, that are present in the granule content of both adrenal and
pituitary glands(24, 25, 26) . Furthermore,
when segments of the luminal domain of PAM were expressed in AtT20
cells as a soluble, secretory proteins, they, like the transmembrane
form, were incorporated into secretory granules(27) .As can
be seen in Fig. 9, the endogenous soluble form of DBH in adrenal
extracts aggregated only modestly when the chromaffin granule content
was titrated to pH 6.0 in the absence of calcium. When adrenal
content was added to pituitary granule extracts prior to the assay, the
major content proteins, including CgA, underwent aggregation at low pH
in the absence of calcium (Fig. 9A, lanes k and l). In this case, DBH was also prominent in the pellet
fractions. This result indicates that under conditions where DBH does
not self-aggregate well, it can interact with other granule content
proteins. When adrenal content aggregation was induced by addition of
calcium to the assay, DBH sedimented (Fig. 9B).
Although homotypic self-aggregation of DBH in the presence of calcium
cannot be ruled out, the data suggest that DBH is in fact
co-aggregating with the Cgs in the chromaffin extracts.
Figure 9:
The soluble form of the chromaffin granule
membrane protein dopamine- -hydroxylase aggregates together with
pituitary and adrenal content proteins. Panel A, aggregation
assays were performed exactly as described in the legend to Fig. 1at the indicated pH values using either 2 mg/ml adrenal
content alone (lanes a-d), 2 mg/ml pituitary content (lanes e-h), or 0.5 mg/ml adrenal mixed with 2 mg/ml
pituitary content protein (lanes i-l). Pellets (P;
lanes a, c, e, g, i, and k) and 30% of the supernatant (S; lanes b, d, f, h, j, and l) fractions were
subjected to SDS-PAGE in the absence of reducing agent. The samples
were transfered to nitrocellulose and stained with Ponceau S (bottom). The nitrocellulose was probed with rabbit antibodies
to bovine DBH and I-protein A and the radioactive bands
detected on a PhosphorImager (top). The adrenal content
proteins (including CgA) do not aggregate at low pH in the absence of
calcium (lanes c and d) but do aggregate when mixed
with the pituitary extract (lanes k and l). Top, the 150-kDa adrenal DBH dimer precipitated in the
pituitary extract in a pH-dependent fashion but only modestly in the
adrenal content itself (compare top, lanes c and d, k, and l). The migration positions of molecular mass standards are
noted at the right. Panel B, adrenal chromaffin
granule content proteins were subjected to the aggregation assay at pH
7.5 (lanes a and b) or 5.8 (lanes c and d) in the presence of 25 mM CaCl as
described in the legend to Fig. 6. Samples were analyzed as in panel A but using the ECL immunoblotting procedure. DBH
aggregated at low pH in the presence of calcium as did CgA. Thus, DBH
can co-aggregate with the pituitary content at low pH under conditions
where it self-aggregates poorly. It also aggregates in the adrenal
extracts in the presence of calcium, conditions that promote
self-aggregation of the chromogranins. The percentage of the indicated
proteins in the pellet fractions (% Aggreg.) is listed at the bottom of each panel. Presented is one of two similar
experiments.
PAM, in
contrast to DBH, could undergo a vigorous pH-dependent aggregation in
the absence of other granule components. A significant fraction of
purified PAM3 (a soluble isoform consisting of virtually the entire
luminal domain) was observed to sediment after reduction of the pH to
5.8 regardless of whether the assay was conducted in the presence of
pituitary or adrenal granule content, or nonaggregating proteins such
as hemoglobin (Fig. 10) or BSA (not shown). However, PAM
self-aggregation was inhibited by CaCl (Fig. 10, lanes e and f). This inhibition was specific for
calcium and not observed in the presence of the same molar equivalents
of potassium ion (data not shown). When added to the pituitary or
adrenal assays in the presence of calcium, PAM did sediment effectively (Fig. 10, lanes k and l), indicating that it
can interact with other granule content proteins.
Figure 10:
A soluble form of peptidyl glycine
-amidating monooxygenase aggregates at low pH both with itself and
with other granule content proteins. Panel A, purified PAM3
(1-2 µg/ml), a soluble form of the protein (see text), was
added to either 1.5 mg/ml hemoglobin (globin; lanes a-f) or
pituitary content (lanes g-l) and the standard aggregation
assays conducted at pH 7.5 (lanes a and b, g and h) or 5.8 (lanes c-f and i-l) as described
under ``Materials and Methods.'' 25 mM CaCl was included in one set of samples in each case (lanes e and f, k and l). Pellet (P; lanes a, c, e,
g, i, and k) and 20% of the supernatant (S; lanes b,
d, f, h, j, and l) samples were analyzed by SDS-PAGE on a
12% gel followed by transfer to nitrocellulose and staining with
Ponceau S (bottom) and immunoblotting using the ECL procedure (top). At low pH, PAM underwent a strong homophilic
aggregation (35% at pH 5.8) in the presence of globin, which did not
itself precipitate (3%, lanes c and d). In comparison
to the samples containing globin, PAM aggregated only slightly better
when incubated with pituitary content proteins at pH 5.8 (41%, lanes i and j). However, in the presence of calcium,
the self-aggregation of PAM was reduced (13%, lanes e and f) and under these conditions PAM still precipitated strongly
in the pituitary samples (57%, lanes k and l). By
comparison, the aggregation of Prl and GH together at pH 5.8 was 19% in
the absence and 17% in the presence of calcium. Panel B,
purified PAM3 was added to 1.5 mg/ml adrenal content proteins or globin
and the assay was performed as described in the legend to Fig. 9. Samples were analyzed as described in panel A using a 10% polyacrylamide gel. In the absence of calcium at pH
5.8, 23% of PAM aggregated in the globin sample and 32% was found in
the pellets of the adrenal samples. In the presence of calcium, PAM
aggregated much better when mixed with adrenal content (55%, lanes
k and l) than with globin (3%, lanes e and f). CgA recovered in the pellet was only 2% in the absence of
calcium but 33% in its presence. Endogenous PAM did not contribute to
the results as it was not readily detectable in immunoblots of
pituitary and adrenal content under these conditions (not shown). Thus,
PAM is capable of associating with granule content proteins at low pH.
The results represent one of two similar
experiments.
DISCUSSION
Proteins traversing the TGN and ISG, the sites of sorting of
constitutive from regulated proteins, are exposed to mildly acidic pH
and high concentrations of calcium
ions(9, 28, 29, 30, 31) .
The maintenance of an acidic pH in the TGN and ISG is known to be
important for granule biogenesis. Treatment of secretory cells with
lysosomotropic amines to dissipate pH gradients blocks maturation of
secretory granules, as has been shown in both pancreatic acinar cells (32, 33) and islet cells (34) . Moreover,
incubation of AtT20 cells with high concentrations of chloroquine
promotes the diversion of POMC from the regulated to the constitutive
secretory pathway(35) . The results presented here showing
spontaneous aggregation of granule proteins in vitro support
the idea that the ionic milieu of the TGN and ISG are prime
contributors to the selective targeting of proteins to granules and to
the condensation of secretory material that is observed to occur by
electron microscopy(1, 2) .
Aggregation of Granule Content ProteinsIn this study,
we have found that the ability to form large aggregates in vitro at mildly acidic pH is a general property of granule content
proteins but not of constitutively secreted proteins. Our results
indicate that aggregation is initiated as the pH is reduced to
6-6.5, the pH range of the TGN(36) , Our data would
therefore be consistent with the formation of small aggregates in the
TGN that continue to coalesce and condense in the ISG, where the pH is
lower and the calcium and protein concentrations higher.The
conditions promoting the precipitation are somewhat different in each
type of granule content. In pituitary extracts, calcium ion is not
required. All of the major pituitary content proteins tested (CgA,
prolactin, growth hormone, POMC, FSH, and LH) precipitate. An important
finding was that the constitutively secreted proteins IgG,
angiotensinogen, and BSA do not co-precipitate with the pituitary
content proteins. Moreover, as demonstrated previously(12) , a
secretory form of the pancreatic membrane protein GP2, which is not
packaged in granules in endocrine cells, does not co-aggregate with
pituitary content proteins. Thus, the packaging of content proteins in
storage granules correlates well with the behavior of the regulated and
constitutive secretory proteins in the aggregation assays in
vitro. Adrenal content proteins, consisting primarily of the
Cgs(15) , do not precipitate under the same ionic conditions as
those of the anterior pituitary gland. Their precipitation requires
calcium, as does the major constituents of these granules, the
chromogranins. Further evidence that it is Cg aggregation being
measured in our assay comes from experiments conducted using a
preparation that consists almost entirely of soluble Cgs, obtained
after chromaffin granule extracts were heated to 100 °C and
centrifuged(37) . The same level of
Ca -dependent aggregation of CgA was observed (e.g.Fig. 6). However, a recent study has provided
evidence that Ca is not required for the
incorporation of proteins into ISGs(38) . The transport of
secretogranin II (CgC) from the TGN to ISGs in permeabilized PC12 cells
was found to be insensitive to chelation of cytosolic Ca and to the addition of the Ca -H ionophore A23187. This suggests that either some protein sorting
in the TGN can occur without aggregation of the Cgs or that sorting in
this system largely occurs later, after formation of ISGs themselves,
where Ca could still play a role. In favor of the
latter explanation is the appearance in the ISGs, with a sorting index
comparable to that of secretogranin II, of the constitutively secreted
protein, heparan sulfate proteoglycan in this study(38) . It is
also possible, however, that interaction of the granule content
proteins with membrane proteins, a process that our data using DBH and
PAM3 suggest may occur at mildly acidic pH even in the absence of
calcium, is sufficient to insure some preferential sorting of these
proteins in the TGN. In favor of this view, CgA and CgB have been
reported to bind to chromaffin granule membranes at low pH in the
absence of Ca (39, 40) . Further
support for the notion that interactions between granule content
proteins themselves are involved in selective packaging of proteins in
granules has been inferred from the properties of the Cgs. Cgs have
been shown to self-aggregate when calcium is
present(7, 8) . Calcium and low pH can also stabilize
the Cg-containing aggregates formed in PC12 and GH4 cells(4) .
At neutral pH in the absence of Ca , the S O -labeled Cgs, while still in the TGN, were
extracted from detergent-permeabilized cells but at pH 6.4 in the
presence of 10 mM Ca , they remained
sedimentable. The behavior of content proteins other than Cgs was not
reported(4) . More importantly, the use of BiP/GRP78, protein
disulfide isomerase, and free glycosaminoglycans as markers of the
constitutive secretory pathway that did not efficiently co-aggregate
with Cgs is problematic. BiP and protein disulfide isomerase are
normally resident endoplasmic reticulum proteins and have not been
shown to exit endocrine secretory cells via the constitutive pathway.
Glycosaminoglycans, in contrast to bona fide constitutively secreted
proteins, are exported from the cell by both constitutive and regulated
pathways(41) . Similarly, Gorr et al.(7) reported that ovalbumin did not co-aggregate with CgA.
However, ovalbumin has not been expressed in endocrine or
neuroendocrine secretory cells; hence it is not known whether it is a
regulated or constitutive secretory protein. Thus it is difficult to
directly relate aggregation experiments using ovalbumin, BiP, protein
disulfide isomerase, or glycosaminoglycan chains to the general problem
of protein sorting to secretory granules. It should be noted that the
aggregation of pancreatic zymogen granule content proteins in vitro at low pH has been previously reported(42) . IgG added to
the assay was also shown not to co-aggregate with amylase and other
pancreatic zymogens.
The Role of Self-aggregating Content
ProteinsSeveral of the individual granule content proteins were
found to homotypically aggregate. Aside from the Cgs, Prl underwent
strong pH-dependent precipitation. Other major granule content proteins
also can self-aggregate. We have found, for example, that insulin will
completely precipitate out of solution by lowering the pH from 7.5 to
6.2 (data not shown) similar to what has been documented
previously(43) . von Willebrand's factor, which is the
major component of endothelial cell Weibel-Palade bodies, also
aggregates at mildly acidic pH(44) . Secretory granule proteins
that do not have the inherent ability to self-aggregate must be
dependent on other proteins to precipitate. Indeed, it has been shown
that parathyroid hormone co-precipitates in vitro with CgA at
pH 5.9 in the presence of Ca (45) . Similarly,
we found that LH, which does not self-aggregate, sedimented efficiently
only when Cg aggregation was induced, either by Prl or by addition of
Ca . Prl by itself, however, could not bring about the
aggregation of LH, highlighting the specificity involved in these types
of protein-protein interactions. Taken together, the experiments
suggest that self-aggregating proteins, like the Cgs, may be critical
for the formation of condensed content in secretory granules.
The Luminal Domains of Membrane Proteins Co-aggregate
with Content ProteinsSoluble forms of three membrane-associated
proteins PAM, adrenal DBH, and, as we have previously shown, pancreatic
GP2(12) , were found to precipitate with content proteins in in vitro assays under conditions where they did not
homotypically self-aggregate well. The soluble forms of the membrane
proteins used in the assays represent almost their entire luminal
domains. In the case of PAM (27) and GP2(12) , the
secretory versions also contain granule packaging information when the
proteins are expressed in the appropriate cell hosts. In chromaffin
granules, DBH is a major membrane constituent (15) and the
soluble subunits can exchange with those of the membrane-bound
tetramer(23) . Thus, it is reasonable to propose that the
interaction observed between content and the luminal segments of these
membrane proteins could also occur when they are in their
membrane-bound state. The ability of exposed luminal domains of
membrane proteins to associate with the content proteins, at least in vitro, may be a general feature of many granule membrane
proteins. For example, pH-dependent binding of a putative chromaffin
granule Ca channel/inositol trisphosphate
receptor-related membrane protein to CgA has also been
observed(46) . We speculate that similar interactions between
the luminal segments of membrane and the content proteins may also
occur during granule formation. These interactions could potentially
play an important role in the incorporation of membrane proteins
themselves into granules as they could be segregated in concert with
the content proteins.
Protein Aggregation and Selective Packaging of Proteins
in Secretory GranulesAs noted above, content protein
aggregation is a distinctive feature of granule formation that is
readily observed by electron microscopy. Our data support those from
previous studies and show that constitutively secreted proteins
aggregate significantly less effectively in vitro than granule
content proteins from pituitary and adrenal medulla. In principle, this
would be consistent with an important role for aggregation in excluding
nonaggregating constitutively secreted proteins from regions where
sorting of granule content proteins is taking place. However, there is
evidence that suggests that aggregation alone is not sufficient to
ensure the packaging of all proteins in secretory granules. The
Ca -induced aggregation of CgB in
detergent-permeabilized TGN vesicles, for example, is maintained in a
variant whose disulfide bond has been disrupted, even though this
protein does not enter the secretory granules of PC12
cells(47) . The interpretation of this result is that binding
of granule content proteins to the membrane in the TGN, possibly
mediated by specific receptors, is of greatest consequence. Hence the
formation of a protein aggregate would not ensure incorporation into
secretory granules but could potentially increase the efficacy of
membrane-content protein interactions. Further studies will be
necessary to characterize the nature of content protein association
with membranes and the potential role of the granule membrane proteins
in secretory granule formation in vivo.
FOOTNOTES
- *
- This work was supported in part by National
Institutes of Health Grant DK44238. The costs of publication of this
article were defrayed in part by the payment of page charges. This
article must therefore by hereby marked
``advertisement'' in accordance with 18 U.S.C.
Section 1734 solely to indicate this fact.
- §
- Recipient of an Ella Fitzgerald Award from the
American Heart Association, NYC affiliate.
- ¶
- Crawford-Maynard Established Investigator of
the American Heart Association, NYC affiliate. To whom correspondence
should be addressed: Dept. Cell Biology, NYU Medical Center, 550 First
Ave., New York, NY 10016. Tel: 212-263-5812; Fax: 212-263-8139.
- (
) - The abbreviations used are: TGN, trans-Golgi network; ISG, immature secretory granule; IgG,
immunoglobulin G; BSA, bovine serum albumin; GH, growth hormone; Prl,
prolactin; Cg, chromo/secretogranin; DBH, dopamine
-hydroxylase;
PAM, peptidyl glycine -amidating monooxygenase; FSH, follicle
stimulating hormone; POMC, pro-opiomelanocortin; IGF-1, insulin-like
growth factor 1; ACTH, adrenocorticotropic hormone; PAGE,
polyacrylamide gel electrophoresis; MES, 4-morpholineethanesulfonic
acid; LH, luteinizing hormone.
ACKNOWLEDGEMENTS
We thank T. Brown and M. Parameswaran for expert
technical assistance, and F. Forcino and J. Culkin for photographic
services. We also thank Dr. Dominique Aunis and Dr. Ruth Hogue
Angeletti for their gifts of antibodies, and Drs. Betty Eipper and
Richard Mains for providing antibodies to PAM and purified PAM3 and for
helpful discussion.
REFERENCES
- Schnabel, E., Mains, R.
E., and Farquhar, M. G. (1989) Mol. Endocrinol. 3, 1223-1235
[Abstract/Free Full Text]
- Rambourg, A., Clermont,
Y., Chretien, M., and Olivier, L. (1992) Anat. Rec. 232, 169-179
[CrossRef][Medline]
[Order article via Infotrieve]
- Jamieson, J. D., and
Palade, G. E. (1971) J. Cell Biol. 48, 503-522
[Abstract/Free Full Text]
- Chanat, E., and Huttner,
W. B. (1991) J. Cell Biol. 115, 1505-1519
[Abstract/Free Full Text]
- Grimes, M., and Kelly, R.
B. (1992) J. Cell Biol. 117, 539-549
[Abstract/Free Full Text]
- Kuliawat, R., and Arvan,
P. (1992) J. Cell Biol. 118, 521-529
[Abstract/Free Full Text]
- Gorr, S. U., Shioi, J.,
and Cohn, D. V. (1989) Am. J. Physiol. 257, E247-254
- Yoo, S. H., and Albanesi,
J. P. (1991) J. Biol. Chem. 266, 7740-7745
[Abstract/Free Full Text]
- Orci, L., Ravazzola, M.,
Storch, M. J., Anderson, R. G., Vassalli, J. D., and Perrelet, A. (1987) Cell 49, 865-868
[CrossRef][Medline]
[Order article via Infotrieve]
- Nolan, J., Fonseca, R.,
and Angeletti, R. H. (1985) Arch. Biochem. Biophys. 240, 257-264
[CrossRef][Medline]
[Order article via Infotrieve]
- Smith, A. D., and
Winkler, H. (1967) Biochem. J. 103, 480-482
[Medline]
[Order article via Infotrieve]
- Colomer, V., Lal, K.,
Hoops, T. C., and Rindler, M. J. (1994) EMBO J. 13, 3711-3719
[Medline]
[Order article via Infotrieve]
- Kadner, S. S., Katz, J.,
Berliner, M., Levitz, M., and Finlay, T. H. (1984) Endocrinology 155, 2406-2417
- Giannattasio, G.,
Zanini, A., and Meldolesi, J. (1975) J. Cell Biol. 64, 246-251
[Abstract/Free Full Text]
- Winkler, H., Apps, D.
K., and Fischer, C. R. (1986) Neuroscience 18, 261-290
[CrossRef][Medline]
[Order article via Infotrieve]
- Rosa, P., Weiss, U.,
Pepperkok, R., Ansorge, W., Niehrs, C., Stelzer, E. H., and Huttner, W.
B. (1989) J. Cell Biol. 109, 17-34
[Abstract/Free Full Text]
- Deschepper, C. F., and
Reudelhuber, T. L. (1990) Hypertension 16, 147-153
[Abstract/Free Full Text]
- Mitra, A., Song, L., and
Fricker, L. D. (1994) J. Biol. Chem. 269, 19876-19881
[Abstract/Free Full Text]
- Schmidt, W. K., and
Moore, H.-P. H. (1994) J. Biol. Chem. 269, 27115-27124
[Abstract/Free Full Text]
- Bassetti, M., Huttner,
W. B., Zanini, A., and Rosa, P. (1990) J. Histochem.
Cytochem. 38, 1353-1363
[Abstract]
- Scammell, J. G., Rosa,
P., Hille, A., and Huttner, W. B. (1990) J. Histochem.
Cytochem. 38, 949-956
[Abstract]
- Ozawa, H., Picart, R.,
Barret, A., and Tougard, C. (1994) J. Histochem.
Cytochem. 42, 1097-1107
[Abstract]
- Dhawan, S., Duong, L.
T., Ornberg, R. L., and Fleming, P. J. (1987) J. Biol.
Chem. 262, 1869-1875
[Abstract/Free Full Text]
- Eipper, B. A., May, V.,
and Braas, K. M. (1988) J. Biol. Chem. 263, 8371-8399
[Abstract/Free Full Text]
- May, V., Cullen, E. I.,
Braas, K. M., and Eipper, B. A. (1988) J. Biol. Chem. 263, 7550-7554
[Abstract/Free Full Text]
- Braas, A. R., Stoffers,
D. A., Eipper, B. A., and May, V. (1989) Mol.
Endocrinol. 3, 1387-1398
[Abstract/Free Full Text]
- Milgram, S. L., Johnson,
R. C., and Mains, R. E. (1992) J. Cell Biol. 117, 717-728
[Abstract/Free Full Text]
- Orci, L., Ravazzola, M.,
and Anderson, R. G. (1987) Nature 326, 77-79
[CrossRef][Medline]
[Order article via Infotrieve]
- Mata, M., Staple, J.,
and Fink, D. J. (1987) Histochem 87, 339-349
[CrossRef]
- Roos, N. (1988) Scanning Microscopy 2, 323-329
[Medline]
[Order article via Infotrieve]
- Sambrook, J. F. (1990) Cell 61, 197-199
[CrossRef][Medline]
[Order article via Infotrieve]
- von Zastrow, M., Castle,
A. M., and Castle, J. D. (1989) J. Biol. Chem. 264, 6566-6571
[Abstract/Free Full Text]
- Sachs, E., and Jamieson,
J. D. (1992) Am. J. Physiol. 262, G257-266
- Orci, L., Halban, P.,
Perrelet, A., Amherdt, M., Ravazzola, M., and Anderson, R. G. W. (1994) J. Cell Biol. 126, 1149-1156
[Abstract/Free Full Text]
- Moore, H. P., Gumbiner,
B., and Kelly, R. B. (1983) Nature 302, 434-436
[CrossRef][Medline]
[Order article via Infotrieve]
- Orci, L., Ravazzola, M.,
Amherdt, M., Madsen, O., Perrelet, A., Vassalli, J. D., and Anderson,
R. G. (1986) J. Cell Biol. 103, 2273-2281
[Abstract/Free Full Text]
- Gerdes, H.-H., Rosa, P.,
Phillips, E., Baeuerle, P. A., Frank, R., Argos, P., and Huttner, W. B. (1989) J. Biol. Chem. 264, 12009-12015
[Abstract/Free Full Text]
- Carnell, L., and Moore,
H.-P. H. (1994) J. Cell Biol. 127, 693-706
[Abstract/Free Full Text]
- Yoo, S. H. (1993) Biochemistry 32, 8213-8319
[CrossRef][Medline]
[Order article via Infotrieve]
- Yoo, S. H. (1993) Biochim. Biophys. Acta 1179, 239-246
[Medline]
[Order article via Infotrieve]
- Miller, S. G., and
Moore, H. P. (1991) J. Cell Biol. 112, 39-54
[Abstract/Free Full Text]
- Leblond, F. A., Viau,
G., Laine, J., and Lebel, D. (1993) Biochem. J. 291, 289-296
- Kaarsholm, N. C.,
Havelund, S., and Hougaard, P. (1990) Arch. Biochem.
Biophys. 283, 496-502
[CrossRef][Medline]
[Order article via Infotrieve]
- Mayadas, T. N., and
Wagner, D. D. (1989) J. Biol. Chem. 264, 13497-13503
[Abstract/Free Full Text]
- Gorr, S. U., Dean, W.
L., Radley, T. L., and Cohn, D. V. (1988) Bone
Miner. 4, 17-25
- Yoo, S. H. (1994) J. Biol. Chem. 269, 12001-12006
[Abstract/Free Full Text]
- Chanat, E., Weiss, U.,
and Huttner, W. B. (1994) FEBS Lett. 351, 225-230
[CrossRef][Medline]
[Order article via Infotrieve]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. W.Y. Lui-Roberts, F. Ferraro, T. D. Nightingale, and D. F. Cutler
Aftiphilin and {gamma}-Synergin Are Required for Secretagogue Sensitivity of Weibel-Palade Bodies in Endothelial Cells
Mol. Biol. Cell,
December 1, 2008;
19(12):
5072 - 5081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Rindler, C.-f. Xu, I. Gumper, C. Cen, P. Sonderegger, and T. A. Neubert
Calsyntenins Are Secretory Granule Proteins in Anterior Pituitary Gland and Pancreatic Islet {alpha} Cells
J. Histochem. Cytochem.,
April 1, 2008;
56(4):
381 - 388.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Periz, A. C. Gill, L. Hunt, P. Brown, and F. M. Tomley
The Microneme Proteins EtMIC4 and EtMIC5 of Eimeria tenella Form a Novel, Ultra-high Molecular Mass Protein Complex That Binds Target Host Cells
J. Biol. Chem.,
June 8, 2007;
282(23):
16891 - 16898.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Sobota, F. Ferraro, N. Back, B. A. Eipper, and R. E. Mains
Not All Secretory Granules Are Created Equal: Partitioning of Soluble Content Proteins
Mol. Biol. Cell,
December 1, 2006;
17(12):
5038 - 5052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lara-Lemus, M. Liu, M. D. Turner, P. Scherer, G. Stenbeck, P. Iyengar, and P. Arvan
Lumenal protein sorting to the constitutive secretory pathway of a regulated secretory cell
J. Cell Sci.,
May 1, 2006;
119(9):
1833 - 1842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. De Lisle, O. Norkina, E. Roach, and D. Ziemer
Expression of pro-Muclin in pancreatic AR42J cells induces functional regulated secretory granules
Am J Physiol Cell Physiol,
November 1, 2005;
289(5):
C1169 - C1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kim, C.-f. Zhang, Z. Sun, H. Wu, and Y. P. Loh
Chromogranin A Deficiency in Transgenic Mice Leads to Aberrant Chromaffin Granule Biogenesis
J. Neurosci.,
July 27, 2005;
25(30):
6958 - 6961.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Labrador, C. Brun, S. Konig, A. Roatti, and A. J. Baertschi
Peptidyl-Glycine {alpha}-Amidating Monooxygenase Targeting and Shaping of Atrial Secretory Vesicles: Inhibition by Mutated N-Terminal ProANP and PBA
Circ. Res.,
December 10, 2004;
95(12):
e98 - e109.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Boulatnikov and R. C. De Lisle
Binding of the Golgi Sorting Receptor Muclin to Pancreatic Zymogens through Sulfated O-linked Oligosaccharides
J. Biol. Chem.,
September 24, 2004;
279(39):
40918 - 40926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Beuret, H. Stettler, A. Renold, J. Rutishauser, and M. Spiess
Expression of Regulated Secretory Proteins Is Sufficient to Generate Granule-like Structures in Constitutively Secreting Cells
J. Biol. Chem.,
May 7, 2004;
279(19):
20242 - 20249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Bauer, R. L. Overlease, J. L. Lieber, and J. K. Angleson
Retention and stimulus-dependent recycling of dense core vesicle content in neuroendocrine cells
J. Cell Sci.,
May 1, 2004;
117(11):
2193 - 2202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. McGuinness, C. Magoulas, A. K. Sesay, K. Mathers, D. Carmignac, J.-B. Manneville, H. Christian, J. A. Phillips III, and I. C. A. F. Robinson
Autosomal Dominant Growth Hormone Deficiency Disrupts Secretory Vesicles in Vitro and in Vivo in Transgenic Mice
Endocrinology,
February 1, 2003;
144(2):
720 - 731.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hosaka, T. Watanabe, Y. Sakai, Y. Uchiyama, and T. Takeuchi
Identification of a Chromogranin A Domain That Mediates Binding to Secretogranin III and Targeting to Secretory Granules in Pituitary Cells and Pancreatic beta -Cells
Mol. Biol. Cell,
October 1, 2002;
13(10):
3388 - 3399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D. Blagoveshchenskaya, M. J. Hannah, S. Allen, and D. F. Cutler
Selective and Signal-dependent Recruitment of Membrane Proteins to Secretory Granules Formed by Heterologously Expressed von Willebrand Factor
Mol. Biol. Cell,
May 1, 2002;
13(5):
1582 - 1593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B.-J. Sankoorikal, Y. L. Zhu, M. E. Hodsdon, E. Lolis, and P. S. Dannies
Aggregation of Human Wild-Type and H27A-Prolactin in Cells and in Solution: Roles of Zn2+, Cu2+, and pH
Endocrinology,
April 1, 2002;
143(4):
1302 - 1309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Matsushita, M. Takenaka, and H. Ogawa
Porcine Pancreatic alpha -Amylase Shows Binding Activity toward N-Linked Oligosaccharides of Glycoproteins
J. Biol. Chem.,
February 8, 2002;
277(7):
4680 - 4686.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Steveson, G. C. Zhao, H. T. Keutmann, R. E. Mains, and B. A. Eipper
Access of a Membrane Protein to Secretory Granules Is Facilitated by Phosphorylation
J. Biol. Chem.,
October 19, 2001;
276(43):
40326 - 40337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Alam, T. C. Steveson, R. C. Johnson, N. Bäck, B. Abraham, R. E. Mains, and B. A. Eipper
Signaling Mediated by the Cytosolic Domain of Peptidylglycine {alpha}-Amidating Monooxygenase
Mol. Biol. Cell,
March 1, 2001;
12(3):
629 - 644.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. El Meskini, L. Jin, R. Marx, A. Bruzzaniti, J. Lee, R. B. Emeson, and R. E. Mains
A Signal Sequence Is Sufficient for Green Fluorescent Protein to Be Routed to Regulated Secretory Granules
Endocrinology,
February 1, 2001;
142(2):
864 - 873.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. D. Turner and P. Arvan
Protein Traffic from the Secretory Pathway to the Endosomal System in Pancreatic beta -Cells
J. Biol. Chem.,
May 5, 2000;
275(19):
14025 - 14030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Oyarce and B. A. Eipper
Cell Type-specific Storage of Dopamine beta -Monooxygenase
J. Biol. Chem.,
February 4, 2000;
275(5):
3270 - 3278.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K Schmidt, H Dartsch, D Linder, H. Kern, and R Kleene
A submembranous matrix of proteoglycans on zymogen granule membranes is involved in granule formation in rat pancreatic acinar cells
J. Cell Sci.,
January 6, 2000;
113(12):
2233 - 2242.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. H. Datta, H. Youssoufian, P. W. Marks, and B. M. Ewenstein
Targeting of a Heterologous Protein to a Regulated Secretion Pathway in Cultured Endothelial Cells
Blood,
October 15, 1999;
94(8):
2696 - 2703.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bruzzaniti, R. Marx, and R. E. Mains
Activation and Routing of Membrane-tethered Prohormone Convertases 1 and 2
J. Biol. Chem.,
August 27, 1999;
274(35):
24703 - 24713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-U. Gorr, X. F. Huang, D. J. Cowley, R. Kuliawat, and P. Arvan
Disruption of disulfide bonds exhibits differential effects on trafficking of regulated secretory proteins
Am J Physiol Cell Physiol,
July 1, 1999;
277(1):
C121 - C131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-F. Zhang, C. R. Snell, and Y. Peng Loh
Identification of a Novel Prohormone Sorting Signal-Binding Site on Carboxypeptidase E, a Regulated Secretory Pathway-Sorting Receptor
Mol. Endocrinol.,
April 1, 1999;
13(4):
527 - 536.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
L. Lecordier, C. Mercier, L. D. Sibley, and M.-F. Cesbron-Delauw
Transmembrane Insertion of the Toxoplasma gondii GRA5 Protein Occurs after Soluble Secretion into the Host Cell
Mol. Biol. Cell,
April 1, 1999;
10(4):
1277 - 1287.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. D. Ciccotosto, M. R. Schiller, B. A. Eipper, and R. E. Mains
Induction of Integral Membrane PAM Expression in AtT-20 Cells Alters the Storage and Trafficking of POMC and PC1
J. Cell Biol.,
February 8, 1999;
144(3):
459 - 471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Dannies
Protein Hormone Storage in Secretory Granules: Mechanisms for Concentration and Sorting
Endocr. Rev.,
February 1, 1999;
20(1):
3 - 21.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. Han, D. Li, A. K. Stout, K. Takimoto, and E. S. Levitan
Ca2+-Induced Deprotonation of Peptide Hormones Inside Secretory Vesicles in Preparation for Release
J. Neurosci.,
February 1, 1999;
19(3):
900 - 905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Rindler
Carboxypeptidase E, a Peripheral Membrane Protein Implicated in the Targeting of Hormones to Secretory Granules, Co-aggregates with Granule Content Proteins at Acidic pH
J. Biol. Chem.,
November 20, 1998;
273(47):
31180 - 31185.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Karsten, H. Qi, C. J.M. Beckers, A. Reddy, J.-F. Dubremetz, P. Webster, and K. A. Joiner
The Protozoan Parasite Toxoplasma gondii Targets Proteins to Dense Granules and the Vacuolar Space Using Both Conserved and Unusual Mechanisms
J. Cell Biol.,
June 15, 1998;
141(6):
1323 - 1333.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. F. Ruano, J. Perez-Gil, and C. Casals
Effect of Acidic pH on the Structure and Lipid Binding Properties of Porcine Surfactant Protein A. POTENTIAL ROLE OF ACIDIFICATION ALONG ITS EXOCYTIC PATHWAY
J. Biol. Chem.,
June 12, 1998;
273(24):
15183 - 15191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Watanabe, T. Banno, T. Jeziorowski, Y. Ohsawa, S. Waguri, D. Grube, and Y. Uchiyama
Effects of Sex Steroids on Secretory Granule Formation in Gonadotropes of Castrated Male Rats with Respect to Granin Expression
Endocrinology,
June 1, 1998;
139(6):
2765 - 2773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Normant and Y. P. Loh
Depletion of Carboxypeptidase E, a Regulated Secretory Pathway Sorting Receptor, Causes Misrouting and Constitutive Secretion of Proinsulin and Proenkephalin, But Not Chromogranin A
Endocrinology,
April 1, 1998;
139(4):
2137 - 2145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kromer, M. M. Glombik, W. B. Huttner, and H.-H. Gerdes
Essential Role of the Disulfide-bonded Loop of Chromogranin B for Sorting to Secretory Granules Is Revealed by Expression of a Deletion Mutant in the Absence of Endogenous Granin Synthesis
J. Cell Biol.,
March 23, 1998;
140(6):
1331 - 1346.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. VilaPorcile and P. Corvol
Angiotensinogen, Prorenin, and Renin Are Co-localized in the Secretory Granules of All Glandular Cells of the Rat Anterior Pituitary: An Immunoultrastructural Study
J. Histochem. Cytochem.,
March 1, 1998;
46(3):
301 - 312.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. M. Castle and J. D. Castle
Enhanced Glycosylation and Sulfation of Secretory Proteoglycans Is Coupled to the Expression of a Basic Secretory Protein
Mol. Biol. Cell,
March 1, 1998;
9(3):
575 - 583.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Castle and A. Castle
Intracellular Transport and Secretion of Salivary Proteins
Critical Reviews in Oral Biology & Medicine,
January 1, 1998;
9(1):
4 - 22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Wolins, H. Bosshart, H. Kuster, and J. S. Bonifacino
Aggregation As a Determinant of Protein Fate in Post-Golgi Compartments: Role of the Luminal Domain of Furin in Lysosomal Targeting
J. Cell Biol.,
December 29, 1997;
139(7):
1735 - 1745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Yuan, A. Dancis, and R. D. Klausner
Restriction of Copper Export in Saccharomyces cerevisiae to a Late Golgi or Post-Golgi Compartment in the Secretory Pathway
J. Biol. Chem.,
October 10, 1997;
272(41):
25787 - 25793.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Castle, A. Y. Huang, and J. D. Castle
Passive Sorting in Maturing Granules of AtT-20 Cells: The Entry and Exit of Salivary Amylase and Proline-rich Protein
J. Cell Biol.,
July 14, 1997;
138(1):
45 - 54.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-S. Shen and Y. P. Loh
Intracellular misrouting and abnormal secretion of adrenocorticotropin and growth hormone in Cpefat mice associated with a carboxypeptidase E mutation
PNAS,
May 13, 1997;
94(10):
5314 - 5319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Muller, A. Barret, R. Picart, and C. Tougard
Proteolytic Processing of Sulfated Secretogranin II in the trans-Golgi Network of GH3B6 Prolactin Cells
J. Biol. Chem.,
February 7, 1997;
272(6):
3669 - 3673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Milgram, S. Kho, G. Martin, R. Mains, and B. Eipper
Localization of integral membrane peptidylglycine alpha-amidating monooxygenase in neuroendocrine cells
J. Cell Sci.,
January 3, 1997;
110(6):
695 - 706.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. K. Jain, P. B. M. Joyce, and S.-U. Gorr
Aggregation Chaperones Enhance Aggregation and Storage of Secretory Proteins in Endocrine Cells
J. Biol. Chem.,
August 25, 2000;
275(35):
27032 - 27036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Jutras, N. G. Seidah, and T. L. Reudelhuber
A Predicted alpha -Helix Mediates Targeting of the Proprotein Convertase PC1 to the Regulated Secretory Pathway
J. Biol. Chem.,
December 15, 2000;
275(51):
40337 - 40343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. S. Lee, Y. L. Zhu, J. E. Chang, and P. S. Dannies
Acquisition of Lubrol Insolubility, a Common Step for Growth Hormone and Prolactin in the Secretory Pathway of Neuroendocrine Cells
J. Biol. Chem.,
January 5, 2001;
276(1):
715 - 721.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Wu, M. Grabe, S. Adams, R. Y. Tsien, H.-P. H. Moore, and T. E. Machen
Mechanisms of pH Regulation in the Regulated Secretory Pathway
J. Biol. Chem.,
August 24, 2001;
276(35):
33027 - 33035.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. Bell-Parikh, B. A. Eipper, and R. E. Mains
Response of an Integral Granule Membrane Protein to Changes in pH
J. Biol. Chem.,
August 3, 2001;
276(32):
29854 - 29863.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|